{"id":48745,"date":"2020-07-14T00:00:00","date_gmt":"2020-07-13T22:00:00","guid":{"rendered":"https:\/\/biorius.com\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/"},"modified":"2025-01-13T09:57:10","modified_gmt":"2025-01-13T08:57:10","slug":"alteradores-endocrinos-en-europa-reglamento","status":"publish","type":"post","link":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/","title":{"rendered":"Alteradores endocrinos en Europa (Reglamento)"},"content":{"rendered":"&#13;\n<p class=\"wp-block-paragraph\">Alteradores endocrinos en Europa: la OMS define un alterador endocrino como &#8220;una sustancia o mezcla ex\u00f3gena que altera la(s) funci\u00f3n(es) del sistema endocrino y, en consecuencia, causa efectos adversos para la salud en un organismo intacto, o en su progenie, o en (sub)poblaciones&#8221;. Esta definici\u00f3n ha sido mantenida por la <a href=\"https:\/\/ec.europa.eu\/environment\/chemicals\/endocrine\/definitions\/endodis_en.htm\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"undefined (opens in a new tab)\">Uni\u00f3n<\/a> Europea, que inici\u00f3 una serie de desarrollos para regular mejor estas sustancias en el futuro.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Una primera iniciativa importante es un &#8220;chequeo de idoneidad&#8221; realizado por la Comisi\u00f3n Europea. Los disruptores endocrinos est\u00e1n regulados por varios textos legislativos y el objetivo es analizar la coherencia de estos distintos enfoques, identificar posibles lagunas y sinergias y evaluar su impacto colectivo sobre la salud humana y el medio ambiente. En marzo de 2020 finaliz\u00f3 una consulta p\u00fablica y sobre esta base se elaborar\u00e1 una propuesta normativa. Esta iniciativa puede dar lugar a profundos cambios legales a largo plazo.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Paralelamente, la Comisi\u00f3n Europea ha iniciado la evaluaci\u00f3n toxicol\u00f3gica de varias sustancias espec\u00edficas sospechosas de tener propiedades de alteraci\u00f3n endocrina. Entre estas iniciativas en curso, el SCCS (Comit\u00e9 Cient\u00edfico de Seguridad de los Consumidores) empez\u00f3 a evaluar la seguridad de varios ingredientes cosm\u00e9ticos sospechosos:<\/p>&#13;\n\r\n<ul class=\"wp-block-list\">\r\n<li>Actualmente se est\u00e1n revisando 5 materiales de muy alta prioridad<a href=\"https:\/\/ec.europa.eu\/health\/scientific_committees\/consumer_safety\/requests_en\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"undefined (opens in a new tab)\">(el SCCS recibi\u00f3 el mandato<\/a> en febrero de 2020 de emitir un dictamen cient\u00edfico en un plazo de 9 meses):\r\n<ul class=\"wp-block-list\">&#13;\n<li>Benzofenona-3\/Oxibenzona (CAS 131-57-7)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Propilparabeno (CAS 94-13-3)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Resorcinol (CAS 108-46-3)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Octocrileno (CAS 6197-30-4)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Homosalato (CAS 118-56-9)<\/li>&#13;\n<\/ul>\r\n<\/li>\r\n<\/ul>\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>En 2021 se revisar\u00e1n 9 materiales de alta prioridad:\r\n<ul class=\"wp-block-list\">&#13;\n<li>\u00c1cido k\u00f3jico (CAS 501-30-4)*.<\/li>&#13;\n\r\n\r\n&#13;\n<li>4-Metilbencilideno alcanfor\/4-MBC (CAS 36861-47-9)*.<\/li>&#13;\n\r\n\r\n&#13;\n<li>Triclos\u00e1n (CAS 3380-34-5)*.<\/li>&#13;\n\r\n\r\n&#13;\n<li>Triclocarb\u00e1n\/TCC (CAS 101-20-2)*.<\/li>&#13;\n\r\n\r\n&#13;\n<li>Hidroxitolueno butilado\/BHT (CAS 128-37-0)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Benzofenona (CAS 119-61-9)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Salicilato benc\u00edlico (CAS 118-58-1)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Geniste\u00edna (CAS 446-72-0)*.<\/li>&#13;\n\r\n\r\n&#13;\n<li>Daidze\u00edna (CAS 486-66-8)*.<\/li>&#13;\n<\/ul>\r\n<\/li>\r\n<\/ul>\r\n\r\n<ul class=\"wp-block-list\" type=\"1\">\r\n<li>14 materiales de baja prioridad (s\u00f3lo plantean problemas medioambientales y ser\u00e1n revisados por la Agencia Europea de Sustancias y Preparados Qu\u00edmicos o ya han sido considerados seguros por el CCSC):\r\n<ul class=\"wp-block-list\">&#13;\n<li>Butilparabeno (CAS 94-26-8)**<\/li>&#13;\n\r\n\r\n&#13;\n<li>Butilhidroxianisol\/BHA (CAS 25013-16-5)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Etilhexil metoxicinamato(EHMC)\/Octinoxato (CAS 83834-59-7)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Benzofenona-1 (CAS 131-56-6)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Benzofenona-2 (CAS 131-55-5)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Benzofenona-4 (CAS 4065-45-6)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Benzofenona-5 (CAS 6628-37-1)*.<\/li>&#13;\n\r\n\r\n&#13;\n<li>Metilparabeno (CAS 99-76-3)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Ciclopentasiloxano\/D5 (CAS 541-02-6)**<\/li>&#13;\n\r\n\r\n&#13;\n<li>Ciclometicona (CAS 69430-24-6\/556-67-2\/541-02-6\/540-97-6)**.<\/li>&#13;\n\r\n\r\n&#13;\n<li>\u00c1cido salic\u00edlico (CAS 69-72-7)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Butilfenilmetilpropional\/BMHCA (CAS 80-54-6)**<\/li>&#13;\n\r\n\r\n&#13;\n<li>Trifenilfosfato (CAS 115-86-6)<\/li>&#13;\n\r\n\r\n&#13;\n<li>Deltametrina (CAS 52918-63-5)*.<\/li>&#13;\n<\/ul>\r\n<\/li>\r\n<\/ul>\r\n&#13;\n<p class=\"wp-block-paragraph\"><em>* Estos ingredientes no se utilizan (o apenas) en los productos cosm\u00e9ticos hoy en d\u00eda.<\/em><\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\"><em>** Estos ingredientes probablemente estar\u00e1n prohibidos o severamente restringidos antes de que se realice esta evaluaci\u00f3n<a href=\"https:\/\/biorius.com\/butylparaben-on-the-reach-candidate-list-biorius\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"undefined (opens in a new tab)\">(butilparabeno<\/a>, <a href=\"https:\/\/biorius.com\/information-letter-064-october-2019\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"undefined (opens in a new tab)\">butilfenilmetilpropional<\/a>, <a href=\"https:\/\/biorius.com\/es\/cosmetic-news\/d4-y-d5-en-productos-cosmeticos\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"undefined (opens in a new tab)\">ciclopentasiloxano<\/a>).<\/em><\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">A partir de estos dict\u00e1menes cient\u00edficos, pueden elaborarse propuestas normativas destinadas a prohibir o restringir el uso de estos ingredientes en los productos cosm\u00e9ticos. Los cinco primeros dict\u00e1menes cient\u00edficos deber\u00edan estar finalizados para enero de 2021, si las circunstancias excepcionales de Covid-19 lo permiten (ya se ha informado a la industria de que el plazo para presentar datos de seguridad sobre los 9 pr\u00f3ximos ingredientes se ha pospuesto hasta<sup>el 15 de<\/sup> enero de 2021). En esta fase, no se puede estimar el posible resultado de esta revisi\u00f3n cient\u00edfica del CCSC (ni los periodos transitorios que conceder\u00e1 la Comisi\u00f3n Europea en caso de que algunos ingredientes no se consideren seguros).<\/p>&#13;\n\n<div id=\"\" class=\"wp-block-ugb-cta ugb-cta ugb-384074e ugb-cta ugb-cta--v2 ugb-cta--design-plain ugb-main-block\"><style>.ugb-384074e .ugb-button .ugb-button--inner{color:#93D500 !important}.ugb-384074e .ugb-button{border-color:#93D500 !important}.ugb-384074e .ugb-button:hover .ugb-button--inner{color:#93D500 !important}<\/style>\n<div class=\"ugb-inner-block\">\n<div class=\"ugb-block-content\">\n<div class=\"ugb-cta__item\">\n<h3 class=\"ugb-cta__title\">\u00bfAlguna pregunta?<\/h3>\n<div class=\"ugb-button-container\"><a class=\"ugb-button ugb-button--size-normal ugb-button--design-ghost\" href=\"https:\/\/biorius.com\/es\/ponte-en-contacto-con\/\" rel=\"\"><span class=\"ugb-button--inner\">Contacta con nosotros<\/span><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#13; Alteradores endocrinos en Europa: la OMS define un alterador endocrino como &#8220;una sustancia o mezcla ex\u00f3gena que altera la(s) funci\u00f3n(es) del sistema endocrino y,&#8230;<\/p>\n","protected":false},"author":2,"featured_media":46597,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[2292],"tags":[],"ppma_author":[2288],"class_list":["post-48745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reglamento-cosmeticos","author-christophe-brault-chevalier"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alteradores endocrinos en Europa (Reglamento) - Biorius<\/title>\n<meta name=\"description\" content=\"Descubre las \u00faltimas normativas de la UE sobre disruptores endocrinos en cosm\u00e9ticos, incluidas las evaluaciones de sustancias en curso y las futuras estrategias de cumplimiento con Biorius.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alteradores endocrinos en Europa (Reglamento) - Biorius\" \/>\n<meta property=\"og:description\" content=\"Descubre las \u00faltimas normativas de la UE sobre disruptores endocrinos en cosm\u00e9ticos, incluidas las evaluaciones de sustancias en curso y las futuras estrategias de cumplimiento con Biorius.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/\" \/>\n<meta property=\"og:site_name\" content=\"Biorius\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-13T22:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T08:57:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/biorius.com\/wp-content\/uploads\/2023\/10\/books-1845614_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1042\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Christophe Brault-Chevalier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"nicolas.lenaers@biorius.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/\"},\"author\":{\"name\":\"nicolas.lenaers@biorius.com\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/#\\\/schema\\\/person\\\/118636d0af6db915f51e7a434d16faa3\"},\"headline\":\"Alteradores endocrinos en Europa (Reglamento)\",\"datePublished\":\"2020-07-13T22:00:00+00:00\",\"dateModified\":\"2025-01-13T08:57:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/\"},\"wordCount\":577,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/biorius.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/books-1845614_1920.jpg\",\"articleSection\":[\"Reglamento Cosm\u00e9ticos\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/\",\"url\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/\",\"name\":\"Alteradores endocrinos en Europa (Reglamento) - Biorius\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/biorius.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/books-1845614_1920.jpg\",\"datePublished\":\"2020-07-13T22:00:00+00:00\",\"dateModified\":\"2025-01-13T08:57:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/#\\\/schema\\\/person\\\/118636d0af6db915f51e7a434d16faa3\"},\"description\":\"Descubre las \u00faltimas normativas de la UE sobre disruptores endocrinos en cosm\u00e9ticos, incluidas las evaluaciones de sustancias en curso y las futuras estrategias de cumplimiento con Biorius.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#primaryimage\",\"url\":\"https:\\\/\\\/biorius.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/books-1845614_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/biorius.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/books-1845614_1920.jpg\",\"width\":1920,\"height\":1042,\"caption\":\"Discover how the 2019 Omnibus Regulation impacts cosmetics, including new restrictions on Salicylic Acid and updates on prohibited substances.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/cosmetic-news\\\/alteradores-endocrinos-en-europa-reglamento\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/biorius.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alteradores endocrinos en Europa (Reglamento)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/biorius.com\\\/es\\\/\",\"name\":\"Biorius\",\"description\":\"You create dreams we protect them\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/biorius.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/biorius.com\\\/es\\\/#\\\/schema\\\/person\\\/118636d0af6db915f51e7a434d16faa3\",\"name\":\"nicolas.lenaers@biorius.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7450c58c275f611cb86faf5b3b4ac4f1690203c164517e77349b33518fcd563c?s=96&d=mm&r=gf65cae9e2e07fb542ca434cf6ec306ac\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7450c58c275f611cb86faf5b3b4ac4f1690203c164517e77349b33518fcd563c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7450c58c275f611cb86faf5b3b4ac4f1690203c164517e77349b33518fcd563c?s=96&d=mm&r=g\",\"caption\":\"nicolas.lenaers@biorius.com\"},\"url\":\"https:\\\/\\\/biorius.com\\\/it\\\/cosmetic-news\\\/author\\\/nicolas-lenaersbiorius-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alteradores endocrinos en Europa (Reglamento) - Biorius","description":"Descubre las \u00faltimas normativas de la UE sobre disruptores endocrinos en cosm\u00e9ticos, incluidas las evaluaciones de sustancias en curso y las futuras estrategias de cumplimiento con Biorius.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/","og_locale":"es_ES","og_type":"article","og_title":"Alteradores endocrinos en Europa (Reglamento) - Biorius","og_description":"Descubre las \u00faltimas normativas de la UE sobre disruptores endocrinos en cosm\u00e9ticos, incluidas las evaluaciones de sustancias en curso y las futuras estrategias de cumplimiento con Biorius.","og_url":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/","og_site_name":"Biorius","article_published_time":"2020-07-13T22:00:00+00:00","article_modified_time":"2025-01-13T08:57:10+00:00","og_image":[{"width":1920,"height":1042,"url":"https:\/\/biorius.com\/wp-content\/uploads\/2023\/10\/books-1845614_1920.jpg","type":"image\/jpeg"}],"author":"Christophe Brault-Chevalier","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"nicolas.lenaers@biorius.com","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#article","isPartOf":{"@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/"},"author":{"name":"nicolas.lenaers@biorius.com","@id":"https:\/\/biorius.com\/es\/#\/schema\/person\/118636d0af6db915f51e7a434d16faa3"},"headline":"Alteradores endocrinos en Europa (Reglamento)","datePublished":"2020-07-13T22:00:00+00:00","dateModified":"2025-01-13T08:57:10+00:00","mainEntityOfPage":{"@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/"},"wordCount":577,"commentCount":0,"image":{"@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#primaryimage"},"thumbnailUrl":"https:\/\/biorius.com\/wp-content\/uploads\/2023\/10\/books-1845614_1920.jpg","articleSection":["Reglamento Cosm\u00e9ticos"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/","url":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/","name":"Alteradores endocrinos en Europa (Reglamento) - Biorius","isPartOf":{"@id":"https:\/\/biorius.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#primaryimage"},"image":{"@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#primaryimage"},"thumbnailUrl":"https:\/\/biorius.com\/wp-content\/uploads\/2023\/10\/books-1845614_1920.jpg","datePublished":"2020-07-13T22:00:00+00:00","dateModified":"2025-01-13T08:57:10+00:00","author":{"@id":"https:\/\/biorius.com\/es\/#\/schema\/person\/118636d0af6db915f51e7a434d16faa3"},"description":"Descubre las \u00faltimas normativas de la UE sobre disruptores endocrinos en cosm\u00e9ticos, incluidas las evaluaciones de sustancias en curso y las futuras estrategias de cumplimiento con Biorius.","breadcrumb":{"@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#primaryimage","url":"https:\/\/biorius.com\/wp-content\/uploads\/2023\/10\/books-1845614_1920.jpg","contentUrl":"https:\/\/biorius.com\/wp-content\/uploads\/2023\/10\/books-1845614_1920.jpg","width":1920,"height":1042,"caption":"Discover how the 2019 Omnibus Regulation impacts cosmetics, including new restrictions on Salicylic Acid and updates on prohibited substances."},{"@type":"BreadcrumbList","@id":"https:\/\/biorius.com\/es\/cosmetic-news\/alteradores-endocrinos-en-europa-reglamento\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/biorius.com\/es\/"},{"@type":"ListItem","position":2,"name":"Alteradores endocrinos en Europa (Reglamento)"}]},{"@type":"WebSite","@id":"https:\/\/biorius.com\/es\/#website","url":"https:\/\/biorius.com\/es\/","name":"Biorius","description":"You create dreams we protect them","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biorius.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/biorius.com\/es\/#\/schema\/person\/118636d0af6db915f51e7a434d16faa3","name":"nicolas.lenaers@biorius.com","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/7450c58c275f611cb86faf5b3b4ac4f1690203c164517e77349b33518fcd563c?s=96&d=mm&r=gf65cae9e2e07fb542ca434cf6ec306ac","url":"https:\/\/secure.gravatar.com\/avatar\/7450c58c275f611cb86faf5b3b4ac4f1690203c164517e77349b33518fcd563c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7450c58c275f611cb86faf5b3b4ac4f1690203c164517e77349b33518fcd563c?s=96&d=mm&r=g","caption":"nicolas.lenaers@biorius.com"},"url":"https:\/\/biorius.com\/it\/cosmetic-news\/author\/nicolas-lenaersbiorius-com\/"}]}},"authors":[{"term_id":2288,"user_id":0,"is_guest":1,"slug":"christophe-brault-chevalier","display_name":"Christophe Brault-Chevalier","avatar_url":{"url":"https:\/\/biorius.com\/wp-content\/uploads\/2024\/08\/Christophe-Brault-Chevalier.webp","url2x":"https:\/\/biorius.com\/wp-content\/uploads\/2024\/08\/Christophe-Brault-Chevalier.webp"},"author_category":"","user_url":"https:\/\/www.linkedin.com\/in\/christophe-brault-chevalier-779b1524\/","last_name":"Brault-Chevalier","first_name":"Christophe","job_title":"Scientific & Regulatory Affairs Director @ BIORIUS","description":"Christophe Brault-Chevalier is the Scientific &amp; Regulatory Affairs Director at Biorius, bringing over 20 years of experience in the cosmetics industry. He has previously held positions at International Flavors &amp; Fragrances Inc. (IFF) and LVMH, further enhancing his expertise in the field."}],"_links":{"self":[{"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/posts\/48745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/comments?post=48745"}],"version-history":[{"count":0,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/posts\/48745\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/media\/46597"}],"wp:attachment":[{"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/media?parent=48745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/categories?post=48745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/tags?post=48745"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/biorius.com\/es\/wp-json\/wp\/v2\/ppma_author?post=48745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}